Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse MKT  >  Xtant Medical Holdings Inc    XTNT

XTANT MEDICAL HOLDINGS INC

(XTNT)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector news

Xtant Medical : Announces Appointment of Chief Operations Officer

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/12/2019 | 05:30am EDT

(GlobeNewswire) - Xtant Medical Holdings, Inc.(NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the appointment ofRonald Berlin as Vice President & Chief Operations Officer, effective January 1, 2019. Mr. Berlin will report to Michael Mainelli, Xtants Interim Chief Executive Officer.

Ron is an accomplished healthcare executive with significant operations and quality management expertise and we are pleased that he has joined our executive management team, said Michael Mainelli. In addition to the operational leadership he will provide to the organization, he is a strong strategic, cross-functional leader. His appointment continues our commitment to building a highly skilled management team.

Ron Berlin brings over 35 years of operations experience to Xtant. Most recently, Mr. Berlin served as Vice President of Global Operations for CoorsTek Medical. Prior to that role, he held positions of Vice President, Global Strategic Sourcing and Procurement and Vice President, Operations for Integra LifeSciences. Earlier in his career, he was Vice President of Global Operations at Stryker Orthopaedics, which was at the time a division of Stryker Corporation. He is well versed in all aspects of medical device and tissue processing operations and quality assurance. He has a proven track record for improving compliance and quality, cost effectiveness, asset utilization, and continuous improvement programs based on Six Sigma, Kaizen, Lean Implementation, as well as managing the implementation of M&A programs.

Im particularly pleased to be joining this exceptional, newly appointed executive leadership team and look forward to helping the Company continue to transform its business and drive shareholder value, said Ron Berlin.

AboutXtant Medical Holdings, Inc.

Xtant Medical Holdings, Inc.(www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.

COMPANY CONTACTKathie Lenzen, Chief Financial Officer406.388.0480klenzen@xtantmedical.com

(c) Palestine News Network, 2003 - 2019 Provided by SyndiGate Media Inc. (Syndigate.info)., source Middle East & North African Newspapers

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on XTANT MEDICAL HOLDINGS INC
05/29XTANT MEDICAL : Announces NYSE American Acceptance of Plan to Regain Compliance ..
AQ
05/28XTANT MEDICAL HOLDINGS, INC. : Notice of Delisting or Failure to Satisfy a Conti..
AQ
05/28XTANT MEDICAL : Announces NYSE American Acceptance of Plan to Regain Compliance ..
AQ
05/15XTANT MEDICAL : Management's Discussion and Analysis of Financial Condition and ..
AQ
05/15XTANT MEDICAL HOLDINGS, INC. : Results of Operations and Financial Condition, Fi..
AQ
05/15XTANT MEDICAL : Announces First Quarter 2019 Financial Results
AQ
05/08XTANT MEDICAL : to Issue First Quarter 2019 Financial Results on May 15, 2019
AQ
04/05XTANT MEDICAL HOLDINGS, INC. : Notice of Delisting or Failure to Satisfy a Conti..
AQ
04/05Xtant Medical Receives Noncompliance Notice from NYSE American
GL
04/01XTANT MEDICAL : Management's Discussion and Analysis of Financial Condition and ..
AQ
More news
Financials ($)
Sales 2019 69,2 M
EBIT 2019 -8,05 M
Net income 2019 -17,5 M
Debt 2019 -
Yield 2019 -
P/E ratio 2019 -
P/E ratio 2020
Capi. / Sales 2019 0,55x
Capi. / Sales 2020 0,54x
Capitalization 38,3 M
Chart XTANT MEDICAL HOLDINGS INC
Duration : Period :
Xtant Medical Holdings Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 2
Average target price 2,75 $
Spread / Average Target -5,5%
EPS Revisions
Managers
NameTitle
Michael R. Mainelli Chief Executive Officer & Director
Ronald G. Berlin Chief Operating Officer & Vice President
Kathie J. Lenzen CFO & SVP-Finance & Administration
Gregory A. Juda Chief Scientific Officer
John K. Bakewell Director
Sector and Competitors
1st jan.Capitalization (M$)
XTANT MEDICAL HOLDINGS INC84.16%46
THERMO FISHER SCIENTIFIC29.23%106 107
DANAHER CORPORATION36.74%94 446
BOSTON SCIENTIFIC CORPORATION15.85%53 248
INTUITIVE SURGICAL8.98%52 907
ILLUMINA15.98%44 647